Adherence to secondary preventative medications one year post stroke
European Journal of Clinical Pharmacology · 2026-12 · 82 (12)
DOI: 10.1007/s00228-026-04216-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 17.11.2026. Verfasst von Maeve D'Alton und 6 weiteren Autor:innen. Beteiligte Einrichtung: Royal College of Surgeons in Ireland, Dublin 2, Dublin, Ireland. daltonmp@tcd.ie. Hauptthemen laut MEDLINE: Stroke, Secondary Prevention, Hypolipidemic Agents, Drug Monitoring. Die Arbeit nennt 59 Literaturangaben. Gefördert von: RCSI StAR MD programme.
Themen: Schlaganfall
Abstract (Originalsprache)
Adherence to secondary prevention medication is critical to reducing subsequent vascular events This retrospective study of Irish stroke survivors examined adherence to 3 main drug categories Adherence was high in 4 out of 5 stroke survivors High adherence was associated with caregiver involvement and greater disability Purpose Prior stroke is a major risk factor for future stroke events, but this risk can be reduced through a combination of medication and lifestyle interventions. Adherence to secondary preventative medications is critical to reducing subsequent vascular events but is poor in up to 40% of stroke survivors. We examined factors influencing medication adherence in an Irish stroke population.
Methods
This was a retrospective cohort study of patients 1 year post stroke. During an in-home or clinic review, participants were asked about adherence to three medication categories: antithrombotics, antihypertensives and lipid-lowering drugs, using the MMAS-4 questionnaire and medication reconciliation to dichotomise adherence into high and low. The effects of ethnicity, sex, caregiver status and functional outcomes on adherence were examined.
Results
A cohort of 197 stroke survivors was recruited at a median of 386 days post stroke. High adherence was observed in 79% of participants, however, many patients did not know why they were taking their medications. There were no significant differences between ethnicity or sex subgroups. Longer length of stay (p= 0.03), post stroke disability (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Royal College of Surgeons in Ireland, Dublin 2, Dublin, Ireland. daltonmp@tcd.ie.
- Department of Medicine for the Older Person, Connolly Hospital Blanchardstown, Dublin 15, Dublin, D15 X40D, Ireland. daltonmp@tcd.ie.
- Highfield Healthcare, Dublin 9, Dublin, Ireland. daltonmp@tcd.ie.
- Royal College of Surgeons in Ireland, Dublin 2, Dublin, Ireland.
- Department of Medicine for the Older Person, Connolly Hospital Blanchardstown, Dublin 15, Dublin, D15 X40D, Ireland.
- Division of Geriatric Medicine and Gerontology, Center for Transformative Geriatric Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Förderung
- RCSI StAR MD programme
Zitieren
APA
D'Alton, M., Dolan, E., Hamad, M., Donaghy, L., Baby, M., O'Connor, M., & Sheehan, O. C. (2026). Adherence to secondary preventative medications one year post stroke. European Journal of Clinical Pharmacology, 82(12). https://doi.org/10.1007/s00228-026-04216-2
Vancouver
D'Alton M, Dolan E, Hamad M, Donaghy L, Baby M, O'Connor M, et al. Adherence to secondary preventative medications one year post stroke. European Journal of Clinical Pharmacology. 2026;82(12). doi:10.1007/s00228-026-04216-2
BibTeX
@article{DAlton2026,
author = {D'Alton, Maeve and Dolan, Eamon and Hamad, Mahmoud and Donaghy, Lisa and Baby, Maya and O'Connor, Marie and Sheehan, Orla C},
title = {Adherence to secondary preventative medications one year post stroke},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {12},
doi = {10.1007/s00228-026-04216-2}
}
EUVIMED